Clinical Trials Directory

Trials / Unknown

UnknownNCT02908776

MYocardial DAmage AND MIcrobiota STUDY

Gut Flora Modulation for The Prevention of Pci-Related Myocardial Injury - A Randomized, Placebo Controlled, Double Blind, Investigator-Initiated, Single Centre, Preliminary Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
San Filippo Neri General Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

MYDA-MI study is a randomized, placebo controlled, double blind study performed in San Filippo Neri Hospital, Roma, Italy. The planned study duration is 18 months. The objectives are to assess the effects of pre-treatment with probiotic Ecoviesel on the incidence and magnitude of peri-procedural myocardial damage caused by coronary angioplasty in stable patients. 250 patients with chronic stable angina scheduled for a coronary angiography and possible ad hoc angioplasty will be randomized to receive pre-treatment with Ecoviesel sachets (each sachet contains 200 billions bacteria) or Placebo. The pre-treatment dosage will be 4 sachets of probiotic Ecoviesel or placebo for at least 2 weeks before the planned procedure. In patients undergoing angioplasty the same treatment will be continued for 4 weeks after PCI with secondary outcome measures performed at the end of this second stage.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticSachets with Streptococcus thermophilus DSM 32245: 70 billion, bifidobacteria (Bifidobacterium lactis DSM 32246, Bifidobacterium lactis DSM 32247) 40 billion, lactobacilli (Lactobacillus acidophilus DSM 32241, Lactobacillus helveticus DSM 29575, Lactobacillus paracasei DSM 32243, Lactobacillus plantarum DSM 32244, Lactobacillus brevis DSM 27961): 90 billion.
OTHERPlaceboSachets of maltose, flavors and sylicium dioxide, indistinguishable from ecoviesel sachets.

Timeline

Start date
2016-09-01
Primary completion
2019-09-01
Completion
2020-01-01
First posted
2016-09-21
Last updated
2019-04-04

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02908776. Inclusion in this directory is not an endorsement.

MYocardial DAmage AND MIcrobiota STUDY (NCT02908776) · Clinical Trials Directory